<!--HTML document created with Certent Disclosure Management 6.5.8.2-->
<!--Created on: 3/21/2017 8:18:38 AM-->
<html>
	<head>
		<title>
			8-K ATRC BOD Changes
		</title>
	</head>
	<body><div style="margin-left:54pt;margin-right:54pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:428.05pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:71.95pt;text-align:left"><font style="display: inline;font-weight:bold;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;"></font></font>

		</p>

</div>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:16pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:16pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">WASHINGTON, D.C. 20549</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:16pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:14pt;">CURRENT REPORT</font>
		</p>
		<p style="margin:9pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">PURSUANT TO SECTION 13 OR 15(d) </font><font style="display: inline;font-weight:bold;color:#000000;">OF THE</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">SECURITIES EXCHANGE ACT OF 1934</font>
		</p>
		<p style="margin:9pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Date of Report (Date of earliest event reported): </font><font style="display: inline;font-weight:bold;color:#000000;">March 21, 2017</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:16pt;">ATRICURE, INC.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">(Exact name of registrant as specified in charter)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:1.5pt 0pt 0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;font-family:Calibri;font-size:11pt;">
			<tr>
				<td valign="top" style="width:155.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:155.85pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:155.85pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:155.80pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">Delaware</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">000-51470</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">34-1940305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:155.80pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">(State or other jurisdiction</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">(Commission</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">(IRS Employer</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:155.80pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">of incorporation)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">File Number)</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:155.85pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:8pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:1.5pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;font-family:Calibri;font-size:11pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:233.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:233.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">7555 Innovation Way</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Mason, OH</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">45040</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:8pt;">(Address of principal executive offices)</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:233.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:8pt;">(Zip Code)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 64.8pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:9pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">Registrant's telephone number, including area code: (513)&nbsp;755-4100</font>
		</p>
		<p style="margin:9pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">Not Applicable</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:8pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:22.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font></p>
				</td>
				<td valign="top" style="width:361.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:22.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font></p>
				</td>
				<td valign="top" style="width:361.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:22.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font></p>
				</td>
				<td valign="top" style="width:450.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 4pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:22.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font></p>
				</td>
				<td valign="top" style="width:448.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 6pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt solid #000000 ;border-top:1pt none #D9D9D9 ;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 14pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:428.05pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:71.95pt;text-align:left"><font style="display: inline;font-weight:bold;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;"></font></font>

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 14pt"><font style="display: inline;font-size:14pt;"></font>
		</p>
		<p style="margin:13.5pt 0pt 0pt 58.5pt;text-indent: -58.5pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">Item </font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">5</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">.02.</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 43pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;"></font><font style="display: inline;font-weight:bold;font-size:10pt;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Effective</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">March 21, 2017</font><font style="display: inline;color:#000000;font-size:10pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">the Board of Directors (the &#x201C;Board&#x201D;) of AtriCure, Inc. (the &#x201C;Company&#x201D;) </font><font style="display: inline;color:#000000;font-size:10pt;">a</font><font style="display: inline;color:#000000;font-size:10pt;">ppoint</font><font style="display: inline;color:#000000;font-size:10pt;">ed </font><font style="display: inline;color:#000000;font-size:10pt;">Regina Groves and B. Kristine Johnson</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">to serve as </font><font style="display: inline;color:#000000;font-size:10pt;">D</font><font style="display: inline;color:#000000;font-size:10pt;">irector</font><font style="display: inline;color:#000000;font-size:10pt;">s</font><font style="display: inline;color:#000000;font-size:10pt;"> until the next </font><font style="display: inline;color:#000000;font-size:10pt;">A</font><font style="display: inline;color:#000000;font-size:10pt;">nnual </font><font style="display: inline;color:#000000;font-size:10pt;">M</font><font style="display: inline;color:#000000;font-size:10pt;">eeting </font><font style="display: inline;color:#000000;font-size:10pt;">of S</font><font style="display: inline;color:#000000;font-size:10pt;">tock</font><font style="display: inline;color:#000000;font-size:10pt;">holders</font><font style="display: inline;color:#000000;font-size:10pt;">. &nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">The Board has determined that </font><font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves and Ms. Johnson are</font><font style="display: inline;color:#000000;font-size:10pt;"> independent director</font><font style="display: inline;color:#000000;font-size:10pt;">s</font><font style="display: inline;color:#000000;font-size:10pt;"> in accordance with guidelines that the Company has adopted, which </font><font style="display: inline;color:#000000;font-size:10pt;">also</font><font style="display: inline;color:#000000;font-size:10pt;"> comply with the listing standards set forth by The </font><font style="display: inline;color:#000000;font-size:10pt;">N</font><font style="display: inline;color:#000000;font-size:10pt;">ASDAQ</font><font style="display: inline;color:#000000;font-size:10pt;"> Stock Market.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">Also</font><font style="display: inline;color:#000000;font-size:10pt;"> effective March 21, 2017</font><font style="display: inline;color:#000000;font-size:10pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">Michael D. Hooven and Karen P. Robards informed the Bo</font><font style="display: inline;color:#000000;font-size:10pt;">ard that they will not stand for re-election to the Board at the </font><font style="display: inline;color:#000000;font-size:10pt;">Annual Meeting of Stockholders</font><font style="display: inline;color:#000000;font-size:10pt;"> in May 2017.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves has been the Chief Executive Officer at REVA Medical, Inc. (ASX: RVA), since September of 2015. Prior to her current position, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic, a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Afib ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, Afib ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials, and launch novel products in the United States and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic&#x2019;s Cardiac Rhythm Disease Management (&#x201C;CRDM&#x201D;) business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Ms. Johnson is currently </font><font style="display: inline;color:#000000;font-size:10pt;">P</font><font style="display: inline;color:#000000;font-size:10pt;">resident of Affinity Capital Management, a venture capital firm that invests primarily in seed and early-stage health care companies in the United States, a position she has held since 2000. In addition to her role at Affinity, Ms. Johnson currently serves on the </font><font style="display: inline;color:#000000;font-size:10pt;">B</font><font style="display: inline;color:#000000;font-size:10pt;">oards o</font><font style="display: inline;color:#000000;font-size:10pt;">f D</font><font style="display: inline;color:#000000;font-size:10pt;">irectors of Piper Jaffray (NYSE: PJC), The Spectrane</font><font style="display: inline;color:#000000;font-size:10pt;">tics Corporation (NASDAQ: SPNC)</font><font style="display: inline;color:#000000;font-size:10pt;"> and the University of Minnesota Foundation Investment Advisors, as well as the boards of several private entities. Prior to her role at Affinity, Johnson was employed for 17 years at Medtronic, serving most recently as </font><font style="display: inline;color:#000000;font-size:10pt;">S</font><font style="display: inline;color:#000000;font-size:10pt;">enior </font><font style="display: inline;color:#000000;font-size:10pt;">V</font><font style="display: inline;color:#000000;font-size:10pt;">ice </font><font style="display: inline;color:#000000;font-size:10pt;">P</font><font style="display: inline;color:#000000;font-size:10pt;">resident and </font><font style="display: inline;color:#000000;font-size:10pt;">C</font><font style="display: inline;color:#000000;font-size:10pt;">hief </font><font style="display: inline;color:#000000;font-size:10pt;">A</font><font style="display: inline;color:#000000;font-size:10pt;">dministrative </font><font style="display: inline;color:#000000;font-size:10pt;">O</font><font style="display: inline;color:#000000;font-size:10pt;">fficer from 1998 to 1999. Her experience at Medtronic also includes service as </font><font style="display: inline;color:#000000;font-size:10pt;">P</font><font style="display: inline;color:#000000;font-size:10pt;">resident of the </font><font style="display: inline;color:#000000;font-size:10pt;">V</font><font style="display: inline;color:#000000;font-size:10pt;">ascular </font><font style="display: inline;color:#000000;font-size:10pt;">B</font><font style="display: inline;color:#000000;font-size:10pt;">usiness and </font><font style="display: inline;color:#000000;font-size:10pt;">P</font><font style="display: inline;color:#000000;font-size:10pt;">resident of the </font><font style="display: inline;color:#000000;font-size:10pt;">T</font><font style="display: inline;color:#000000;font-size:10pt;">achyarrhythmia </font><font style="display: inline;color:#000000;font-size:10pt;">Management B</font><font style="display: inline;color:#000000;font-size:10pt;">usiness, among other roles.&nbsp; </font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">There is no arrangement or understanding between </font><font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves or Ms. Johnson</font><font style="display: inline;color:#000000;font-size:10pt;"> and any other person pursuant to which </font><font style="display: inline;color:#000000;font-size:10pt;">they</font><font style="display: inline;color:#000000;font-size:10pt;"> &nbsp;w</font><font style="display: inline;color:#000000;font-size:10pt;">ere</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">appoin</font><font style="display: inline;color:#000000;font-size:10pt;">ted as</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">D</font><font style="display: inline;color:#000000;font-size:10pt;">irector</font><font style="display: inline;color:#000000;font-size:10pt;">s</font><font style="display: inline;color:#000000;font-size:10pt;"> of the Company</font><font style="display: inline;color:#000000;font-size:10pt;">, and there </font><font style="display: inline;color:#000000;font-size:10pt;">have been no transactions nor are there any proposed transactions between the Company and </font><font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves or Ms. Johnson</font><font style="display: inline;color:#000000;font-size:10pt;"> that would require disclosure pursuant to Item 404(a) of Regulation S-K.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves and Ms. Johnson</font><font style="display: inline;color:#000000;font-size:10pt;"> will receive compensation for </font><font style="display: inline;color:#000000;font-size:10pt;">their</font><font style="display: inline;color:#000000;font-size:10pt;"> service as director</font><font style="display: inline;color:#000000;font-size:10pt;">s</font><font style="display: inline;color:#000000;font-size:10pt;"> in accordance with the Company&#x2019;s compensation policies for non-employee directors</font><font style="display: inline;color:#000000;font-size:10pt;">.</font>
		</p>
		<p style="margin:9pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">A copy of the press release announcing </font><font style="display: inline;color:#000000;font-size:10pt;">Ms. Groves and Ms. Johnson&#x2019;s</font><font style="display: inline;color:#000000;font-size:10pt;"> appointment is furnished as Exhibit 99.1 and incorporated by reference in this Item 5.02.</font>
		</p>
		<p style="margin:13.5pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:19pt;"><font style="display: inline;font-weight:bold;font-size:10pt;">Item 9.01</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;font-size:10pt;">Financial Statements and Exhibits</font><font style="display: inline;font-weight:bold;font-size:10pt;">.</font></font>
		</p>
		<p style="margin:6pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(d)&nbsp; </font><font style="display: inline;font-size:10pt;">Exhibits</font>
		</p>
		<p style="margin:9pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<a name="part_1_2_4"></a><a name="item_1_31_1"></a><a name="part_1_2_5"></a><a name="item_1_47_1"></a><font style="display: inline;color:#000000;font-size:10pt;text-decoration:underline;">No.</font><font style="display: inline;color:#000000;font-size:10pt;text-decoration:underline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;font-size:10pt;"></font><font style="display: inline;color:#000000;font-size:10pt;text-decoration:underline;">Description</font>
		</p>
		<p style="margin:6pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">99.1</font><font style="display: inline;color:#000000;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;font-size:10pt;"></font><font style="display: inline;color:#000000;font-size:10pt;">Press Release dated </font><font style="display: inline;color:#000000;font-size:10pt;">March 21, 2017</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:428.05pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:71.95pt;text-align:left"><font style="display: inline;font-weight:bold;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;"></font></font>

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font><a name="part_1_2_6"></a><a name="doc_1_2"></a>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">SIGNATURES</font>
		</p>
		<p style="margin:9pt 0pt 12pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:495.00pt;font-family:Calibri;font-size:11pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:252.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:243.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">ATRICURE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:27.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:216.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:27.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:216.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:252.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Dated:&nbsp;&nbsp;March 21, 2017</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:27.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:216.00pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">/s/ M. Andrew Wade</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:27.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:216.00pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">M. Andrew Wade</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:27.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:216.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Senior Vice President and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0.45pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "atrc-20170321x8k.htm", "description": "8-K", "secsgml_size_bytes": 43824}]
{"company-data": {"conformed-name": "AtriCure, Inc.", "cik": "0001323885", "assigned-sic": "3841", "irs-number": "341940305", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51470", "film-number": "17703051"}, "business-address": {"street1": "7555 INNOVATION WAY", "city": "MASON", "state": "OH", "zip": "45040", "phone": "513-755-4100"}, "mail-address": {"street1": "7555 INNOVATION WAY", "city": "MASON", "state": "OH", "zip": "45040"}}
8-K ATRC BOD Changes
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 21, 2017
ATRICURE, INC.
(Exact name of registrant as specified in charter)
﻿
Delaware
000-51470
34-1940305
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
﻿
﻿
﻿
7555 Innovation Way
Mason, OH
45040
(Address of principal executive offices)
(Zip Code)
﻿
Registrant's telephone number, including area code: (513) 755-4100
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
5
.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective
March 21, 2017
,
the Board of Directors (the "Board") of AtriCure, Inc. (the "Company")
a
ppoint
ed
Regina Groves and B. Kristine Johnson
to serve as
D
irector
s
until the next
A
nnual
M
eeting
of S
tock
holders
.
The Board has determined that
Ms. Groves and Ms. Johnson are
independent director
s
in accordance with guidelines that the Company has adopted, which
also
comply with the listing standards set forth by The
N
ASDAQ
Stock Market.
Also
effective March 21, 2017
,
Michael D. Hooven and Karen P. Robards informed the Bo
ard that they will not stand for re-election to the Board at the
Annual Meeting of Stockholders
in May 2017.
Ms. Groves has been the Chief Executive Officer at REVA Medical, Inc. (ASX: RVA), since September of 2015. Prior to her current position, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic, a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Afib ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, Afib ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials, and launch novel products in the United States and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic's Cardiac Rhythm Disease Management ("CRDM") business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006.
Ms. Johnson is currently
P
resident of Affinity Capital Management, a venture capital firm that invests primarily in seed and early-stage health care companies in the United States, a position she has held since 2000. In addition to her role at Affinity, Ms. Johnson currently serves on the
B
oards o
f D
irectors of Piper Jaffray (NYSE: PJC), The Spectrane
tics Corporation (NASDAQ: SPNC)
and the University of Minnesota Foundation Investment Advisors, as well as the boards of several private entities. Prior to her role at Affinity, Johnson was employed for 17 years at Medtronic, serving most recently as
S
enior
V
ice
P
resident and
C
hief
A
dministrative
O
fficer from 1998 to 1999. Her experience at Medtronic also includes service as
P
resident of the
V
ascular
B
usiness and
P
resident of the
T
achyarrhythmia
Management B
usiness, among other roles.
There is no arrangement or understanding between
Ms. Groves or Ms. Johnson
and any other person pursuant to which
they
w
ere
appoin
ted as
D
irector
s
of the Company
, and there
have been no transactions nor are there any proposed transactions between the Company and
Ms. Groves or Ms. Johnson
that would require disclosure pursuant to Item 404(a) of Regulation S-K.
Ms. Groves and Ms. Johnson
will receive compensation for
their
service as director
s
in accordance with the Company's compensation policies for non-employee directors
.
A copy of the press release announcing
Ms. Groves and Ms. Johnson's
appointment is furnished as Exhibit 99.1 and incorporated by reference in this Item 5.02.
Item 9.01
Financial Statements and Exhibits
.
(d)
Exhibits
No.
Description
99.1
Press Release dated
March 21, 2017
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
﻿
ATRICURE, INC.
﻿
﻿
Dated:  March 21, 2017
By:
/s/ M. Andrew Wade
﻿
M. Andrew Wade
﻿
Senior Vice President and Chief Financial Officer
﻿
﻿